1. Home
  2. WBS vs DVA Comparison

WBS vs DVA Comparison

Compare WBS & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Webster Financial Corporation

WBS

Webster Financial Corporation

HOLD

Current Price

$68.09

Market Cap

10.6B

Sector

Finance

ML Signal

HOLD

Logo DaVita Inc.

DVA

DaVita Inc.

HOLD

Current Price

$154.53

Market Cap

10.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WBS
DVA
Founded
1935
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Misc Health and Biotechnology Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6B
10.1B
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
WBS
DVA
Price
$68.09
$154.53
Analyst Decision
Buy
Hold
Analyst Count
15
4
Target Price
$73.71
$156.75
AVG Volume (30 Days)
4.7M
730.0K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
2.34%
N/A
EPS Growth
N/A
N/A
EPS
N/A
9.84
Revenue
N/A
$13,643,069,000.00
Revenue This Year
$5.88
$3.85
Revenue Next Year
$6.04
$3.07
P/E Ratio
$12.28
$15.90
Revenue Growth
N/A
6.46
52 Week Low
$39.43
$101.00
52 Week High
$74.00
$159.42

Technical Indicators

Market Signals
Indicator
WBS
DVA
Relative Strength Index (RSI) 45.62 59.71
Support Level $67.06 $146.05
Resistance Level $73.94 $158.31
Average True Range (ATR) 0.81 3.81
MACD -0.05 -0.46
Stochastic Oscillator 37.19 75.16

Price Performance

Historical Comparison
WBS
DVA

About WBS Webster Financial Corporation

Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania. The company's segment includes Commercial Banking, HSA Bank, and Consumer Banking. It generates maximum revenue from the Commercial Banking segment.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.

Share on Social Networks: